Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca2+-dependent.
Saved in:
| Title: | Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca2+-dependent. |
|---|---|
| Authors: | Abeyawardhane DL; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Sevdalis SE; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Adipietro KA; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Godoy-Ruiz R; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Varney KM; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Nawaz IF; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA., Spittel AX; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA., Hunter D; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Rustandi RR; Merck & Co. Inc., Kenilworth, NJ, USA., Silin VI; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; National Institute of Standards and Technology, Gaithersburg, MD, USA., des Georges A; Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY, USA.; Department of Chemistry and Biochemistry, City College of New York, New York, NY, USA.; PhD Programs in Biochemistry and Chemistry, Graduate Center, City University of New York, New York, NY, USA., Cook ME; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA., Pozharski E; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA. epozharskiy@som.umaryland.edu.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA. epozharskiy@som.umaryland.edu.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA. epozharskiy@som.umaryland.edu., Weber DJ; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA. dweber@som.umaryland.edu.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA. dweber@som.umaryland.edu.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA. dweber@som.umaryland.edu. |
| Source: | Communications biology [Commun Biol] 2025 Jun 09; Vol. 8 (1), pp. 901. Date of Electronic Publication: 2025 Jun 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40490540 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca<superscript>2+</superscript>-dependent. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Abeyawardhane+DL%22">Abeyawardhane DL</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sevdalis+SE%22">Sevdalis SE</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Adipietro+KA%22">Adipietro KA</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Godoy-Ruiz+R%22">Godoy-Ruiz R</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Varney+KM%22">Varney KM</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Nawaz+IF%22">Nawaz IF</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Spittel+AX%22">Spittel AX</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hunter+D%22">Hunter D</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rustandi+RR%22">Rustandi RR</searchLink>; Merck & Co. Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Silin+VI%22">Silin VI</searchLink>; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA.; National Institute of Standards and Technology, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22des+Georges+A%22">des Georges A</searchLink>; Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY, USA.; Department of Chemistry and Biochemistry, City College of New York, New York, NY, USA.; PhD Programs in Biochemistry and Chemistry, Graduate Center, City University of New York, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cook+ME%22">Cook ME</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Pozharski+E%22">Pozharski E</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA. epozharskiy@som.umaryland.edu.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA. epozharskiy@som.umaryland.edu.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA. epozharskiy@som.umaryland.edu.<br /><searchLink fieldCode="AU" term="%22Weber+DJ%22">Weber DJ</searchLink>; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA. dweber@som.umaryland.edu.; Institute for Bioscience and Biotechnology Research (IBBR), University of Maryland, Rockville, MD, USA. dweber@som.umaryland.edu.; The Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA. dweber@som.umaryland.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101719179%22">Communications biology</searchLink> [Commun Biol] 2025 Jun 09; Vol. 8 (1), pp. 901. <i>Date of Electronic Publication: </i>2025 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+UK%22">Nature Publishing Group UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101719179 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2399-3642 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223993642%22">23993642 </searchLink><i>NLM ISO Abbreviation: </i>Commun Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40490540 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42003-025-08343-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 901 Titles: – TitleFull: Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca2+-dependent. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abeyawardhane DL – PersonEntity: Name: NameFull: Sevdalis SE – PersonEntity: Name: NameFull: Adipietro KA – PersonEntity: Name: NameFull: Godoy-Ruiz R – PersonEntity: Name: NameFull: Varney KM – PersonEntity: Name: NameFull: Nawaz IF – PersonEntity: Name: NameFull: Spittel AX – PersonEntity: Name: NameFull: Hunter D – PersonEntity: Name: NameFull: Rustandi RR – PersonEntity: Name: NameFull: Silin VI – PersonEntity: Name: NameFull: des Georges A – PersonEntity: Name: NameFull: Cook ME – PersonEntity: Name: NameFull: Pozharski E – PersonEntity: Name: NameFull: Weber DJ IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 06 Text: 2025 Jun 09 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2399-3642 Numbering: – Type: volume Value: 8 – Type: issue Value: 1 Titles: – TitleFull: Communications biology Type: main |
| ResultId | 1 |